Type6
Transformative medicines against kinase-addicted diseases.
Novato, United States · Founded 2019 · $3.7M raised
- Headquarters
- Novato, California
- Employees
- 1–10
- Founded
- 2019
- Business Model
- B2B
- Total Funding
- $3.7M
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Founded in 2019, Type6 Therapeutics pioneers OFF-state kinase inhibition using computational biology, multivalent chemistry, and allostery-aware drug design. Its lead CDK2 program shows 100x greater selectivity than competing inhibitors and a dual mechanism of potent inhibition plus targeted degradation, targeting aggressive cancers with p53 or MYC alterations.
Summary
Type6 is a SaaS company based in Novato, United States, founded in 2019. It has raised $3.7M in total across 1 round. Investors include Reinforced Ventures.
Funding History
Investors
Similar Companies
OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...
Databricks provides a unified data and AI platform that helps enterprises build and run applicati...
Stripe provides payments, billing, money-management, fraud-prevention, and identity tools that he...
Aramark delivers food, facilities-management, hospitality, refreshment, and supply-chain services...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/type6"><img src="https://indexed.vc/api/badge/company/type6" alt="Type6 on Indexed.vc" width="260" height="76" /></a>